WASHINGTON _ Federal officials have undermined the national program to find medicines to protect Americans against chemical, biological or radiological attacks, the head of a San Diego biotech company will tell Congress Wednesday.

WASHINGTON _ At first, Richard Hollis thought his firm would be a "poster child" for the government's BioShield program to stockpile medical antidotes in case terrorists attack with nuclear, biological or chemical weapons.

By STEVE MITCHELL Hollis-Eden shares plunged nearly 30 percent Thursday after the U.S. government rejected its Neumune for treating radiation sickness in the event of a terrorist attack, but some analysts think this is merely investor hysteria and the stock remains a good investment.

By Marlena Hartz, Clovis News Journal, N.M. Jun. 7--The will of 580 people entrusted the Division 2 magistrate judge position to incumbent Richard Hollis during the Tuesday primary election. Hollis, a Republican, will run unopposed in November.